RecruitingPhase 3NCT06961214
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Sponsor: GlaxoSmithKline
Bangor, ME · +56 more sites
3 recruiting copd studies with a site in Bangor, ME.
Sponsor: GlaxoSmithKline
Bangor, ME · +56 more sites
Sponsor: Pfizer
Bangor, ME · +60 more sites
Sponsor: GlaxoSmithKline
Bangor, ME · +41 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.